ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Stefano Forlani
Ruggero De Paulis
Luigi Chiariello
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Forlani, S.
Right arrow Articles by Chiariello, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Forlani, S.
Right arrow Articles by Chiariello, L.
Related Collections
Right arrow Electrophysiology - arrhythmias

Ann Thorac Surg 2002;74:720-726
© 2002 The Society of Thoracic Surgeons

Original article: cardiovascular

Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting

Stefano Forlani, MD, PhD*a, Ruggero De Paulis, MDa, Stefano de Notaris, MDa, Paolo Nardi, MDa, Fabrizio Tomai, MDa, Igino Proietti, MDa, Anna S. Ghini, MDa, Luigi Chiariello, MDa

a Division of Cardiac Surgery, "Tor Vergata," University of Rome, Rome, Italy

* Address reprint requests to Dr Forlani, Cattedra di Cardiochirurgia, Università di Roma "Tor Vergata," European Hospital, Via Portuense 700, 00149 Rome, Italy
e-mail: hhstel{at}tiscali.it

Presented at the Thirty-eighth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 28–30, 2002.

Background. Atrial fibrillation (AF) is a common complication reported in 20% to 40% of patients after coronary operations. Sotalol alone and magnesium alone have been shown to partially decrease the incidence of AF. The goal of this study was to evaluate the efficacy of these two pharmacological agents, used alone or in combination, to reduce postoperative AF.

Methods. Two hundred seven consecutive coronary artery bypass patients (mean age 62 ± 11 years) were randomized to receive sotalol alone (80 mg twice daily for 5 days starting from the morning of the first postoperative day) (group S), magnesium alone (1.5 g daily for 6 days starting in the operating room just before cardiopulmonary bypass) (group M), both pharmacologic agents at the same dosages (group S+M), or no antiarrhythmic agents (group CTR). All patients with an ejection fraction less than 0.40 were excluded.

Results. The incidence of postoperative AF was 11.8% (6/51) in the S group, 14.8% (8/54) in the M group, 1.9% (1/52) in the S+M group, and 38% (19/50) in the CTR group. The following differences were significant: group CTR versus groups S, M, and S+M with values of p = 0.002, p = 0.007 and p < 0.0001, respectively; and group S+M versus groups S and M with p = 0.04 and p = 0.01, respectively.

Conclusions. Incidence of AF after coronary operation was significantly reduced by the administration of sotalol alone and magnesium alone; more importantly, the incidence was further reduced by combining these agents.




This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
J. R. Kapoor
Combination Prophylactic Therapy for Post-Operative Atrial Fibrillation
J. Am. Coll. Cardiol., July 29, 2008; 52(5): 397 - 397.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
N. Echahidi, P. Pibarot, G. O'Hara, and P. Mathieu
Reply
J. Am. Coll. Cardiol., July 29, 2008; 52(5): 397 - 398.
[Full Text] [PDF]

Home page
 J Intensive Care MedHome page
M. E. Sleeswijk, J. E. Tulleken, T. Van Noord, J. H. J. M. Meertens, J. J. M. Ligtenberg, and J. G. Zijlstra
Efficacy of magnesium-amiodarone step-up scheme in critically ill patients with new-onset atrial fibrillation: a prospective observational study.
J Intensive Care Med, January 1, 2008; 23(1): 61 - 66.
[Abstract] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
K. Iino, N. Yui, T. Ooya, R. Kawabata, S. Tomita, and G. Watanabe
Successful low-energy cardioversion using a novel biodegradable gel pad: Feasibility of treating postoperative atrial fibrillation in animals.
J. Thorac. Cardiovasc. Surg., December 1, 2007; 134(6): 1519 - 1525.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
F. Wiesbauer, O. Schlager, H. Domanovits, B. Wildner, G. Maurer, M. Muellner, H. Blessberger, and M. Schillinger
Perioperative {beta}-Blockers for Preventing Surgery-Related Mortality and Morbidity: A Systematic Review and Meta-Analysis
Anesth. Analg., January 1, 2007; 104(1): 27 - 41.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
J. Dunning, T. Treasure, M. Versteegh, S. A.M. Nashef, and on behalf of the EACTS Audit and Guidelines Commit
Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery
Eur. J. Cardiothorac. Surg., December 1, 2006; 30(6): 852 - 872.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
D. C. Burgess, M. J. Kilborn, and A. C. Keech
Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis
Eur. Heart J., December 1, 2006; 27(23): 2846 - 2857.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
N. N. Henyan, E. L. Gillespie, C. M. White, J. Kluger, and C. I. Coleman
Impact of Intravenous Magnesium on Post-Cardiothoracic Surgery Atrial Fibrillation and Length of Hospital Stay: A Meta-Analysis
Ann. Thorac. Surg., December 1, 2005; 80(6): 2402 - 2406.
[Abstract] [Full Text] [PDF]

Home page
 SEMIN CARDIOTHORAC VASC ANESTHHome page
R. Kailasam, C. A. Palin, and C. W. Hogue Jr
Atrial Fibrillation After Cardiac Surgery: An Evidence-Based Approach to Prevention
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2005; 9(1): 77 - 85.
[Abstract] [PDF]

Home page
 Am J Health Syst PharmHome page
M. L. Brackbill and L. Moberg
Magnesium sulfate for prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting
Am. J. Health Syst. Pharm., February 15, 2005; 62(4): 397 - 399.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. J. DiDomenico and M. G. Massad
Pharmacologic Strategies for Prevention of Atrial Fibrillation After Open Heart Surgery
Ann. Thorac. Surg., February 1, 2005; 79(2): 728 - 740.
[Abstract] [Full Text] [PDF]

Home page
 ICVTSHome page
A. Rostron, A. Sanni, and J. Dunning
Does magnesium prophylaxis reduce the incidence of atrial fibrillation following coronary bypass surgery?
Interactive CardioVascular and Thoracic Surgery, February 1, 2005; 4(1): 52 - 58.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
H. Kohno, T. Koyanagi, H. Kasegawa, and M. Miyazaki
Three-Day Magnesium Administration Prevents Atrial Fibrillation After Coronary Artery Bypass Grafting
Ann. Thorac. Surg., January 1, 2005; 79(1): 117 - 126.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
S. R. Hazelrigg, T. M. Boley, I. B. Cetindag, K. P. Moulton, G. L. Trammell, J. E. Polancic, T. S. Shawgo, J. A. Quin, and S. Verhulst
The efficacy of supplemental magnesium in reducing atrial fibrillation after coronary artery bypass grafting
Ann. Thorac. Surg., March 1, 2004; 77(3): 824 - 830.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. N. Patel, B. L. Hamman, A. N. Patel, R. F. Hebeler, R. E. Wood, C. A. Cockerham, B. A. Willey, and H. C. Urschel Jr
Epicardial atrial defibrillation: successful treatment of postoperative atrial fibrillation
Ann. Thorac. Surg., March 1, 2004; 77(3): 831 - 837.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The Society of Thoracic Surgeons.